The SEAMO Resources & Audit Committee is chaired by Dr. Tarit Saha and is comprised of nine members.
After 49 years working at Queen’s University in the Department of Pathology and Molecular Medicine, Dr. Paul Manley is retiring in 2022.
Starting July 1, 2022 Mr. John Sheridan will be taking over from Mr. George Thomson as Chair of the SEAMO Governing Committee and Ms. Susan Fitzpatrick will be joining SEAMO as the new Vice Chair and Chair of the Nominations & Governance Development Committee.
SEAMO was pleased to previously announce the winners of the Global Health Development Fund competition. Now, we would like to share more about the projects from each of our winners.
Did you know an estimated 4.6 million Canadians have hypertension?
If you are a fully-funded SEAMO physician and interested in joining either the Resources Committee or the Nominations & Governance Development Committee, please email seamo@queensu.ca by Friday, May 27, 2022 @ 4 p.m.
The Nominations and Governance Development Committee (NGDC) is one of SEAMO’s standing committees that reports back to the Governing Committee. Mr. John Sheridan has been Chair of this Committee and Vice-Chair of the Governing Committee for the past three years after being recruited by current Board Chair Mr. George Thomson.
Dr. Jacob Rullo is a SEAMO-funded clinician scientist in the Department of Ophthalmology, cross-appointed to the Departments of Biomedical and Molecular Sciences and Medicine, and, in addition to completing his residency at Queen’s, has been here since July 2020.
SEAMO is pleased to welcome two new physicians to the Department of Medicine in May 2022.
Learn more from two of our Innovation Fund 2021 winners: Dr. Yanping Gong and Dr. Sulaiman Nanji